Our laboratory was the first to report that such biased signaling is also used by chemokines to direct the biological properties of CD4+ T cells in controlling effector T cell function vs. tolerance to self (4, 5), and perhaps in controlling anti-cancer immunity (6). Here, CD4 is linked to cancer.